These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30651719)

  • 1. Correction to: Next-generation sequencing-based genetic landscape and its clinical implications for Chinese acute myeloid leukemia patients.
    Cao XX; Cai H; Mao YY; Wu Q; Zhang L; Zhou DB; Li J
    Cancer Cell Int; 2019; 19():14. PubMed ID: 30651719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in
    Patkar N; Kodgule R; Kakirde C; Raval G; Bhanshe P; Joshi S; Chaudhary S; Badrinath Y; Ghoghale S; Kadechkar S; Khizer SH; Kannan S; Shetty D; Gokarn A; Punatkar S; Jain H; Bagal B; Menon H; Sengar M; Khattry N; Tembhare P; Subramanian P; Gujral S
    Oncotarget; 2019 Jan; 10(5):617. PubMed ID: 30728913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-generation sequencing-based genetic landscape and its clinical implications for Chinese acute myeloid leukemia patients.
    Cao XX; Cai H; Mao YY; Wu Q; Zhang L; Zhou DB; Li J
    Cancer Cell Int; 2018; 18():215. PubMed ID: 30598640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Genetic landscape of preterm birth due to cervical insufficiency: Comprehensive gene analysis and patient next-generation sequencing data interpretation.
    PLOS ONE Staff
    PLoS One; 2021; 16(3):e0249483. PubMed ID: 33765060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-generation sequencing reveals gene mutations landscape and clonal evolution in patients with acute myeloid leukemia.
    Chen X; Zhu H; Qiao C; Zhao S; Liu L; Wang Y; Jin H; Qian S; Wu Y
    Hematology; 2021 Dec; 26(1):111-122. PubMed ID: 33491606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Landscape of Acute Myeloid Leukemia Interrogated by Next-generation Sequencing: A Large Cancer Center Experience.
    Hussaini MO; Mirza AS; Komrokji R; Lancet J; Padron E; Song J
    Cancer Genomics Proteomics; 2018; 15(2):121-126. PubMed ID: 29496691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and prognostic significance of genetic mutations in acute myeloid leukemia based on a targeted next-generation sequencing technique.
    Wang RQ; Chen CJ; Jing Y; Qin JY; Li Y; Chen GF; Zhou W; Li YH; Wang J; Li DW; Zhao HM; Wang BH; Wang LL; Wang H; Wang MZ; Gao XN; Yu L
    Cancer Med; 2020 Nov; 9(22):8457-8467. PubMed ID: 32970934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing.
    Malmberg EB; Ståhlman S; Rehammar A; Samuelsson T; Alm SJ; Kristiansson E; Abrahamsson J; Garelius H; Pettersson L; Ehinger M; Palmqvist L; Fogelstrand L
    Eur J Haematol; 2017 Jan; 98(1):26-37. PubMed ID: 27197529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice.
    Lin PH; Li HY; Fan SC; Yuan TH; Chen M; Hsu YH; Yang YH; Li LY; Yeh SP; Bai LY; Liao YM; Lin CY; Hsieh CY; Lin CC; Lin CH; Lien MY; Chen TT; Ni YH; Chiu CF
    Cancer Med; 2017 Feb; 6(2):349-360. PubMed ID: 28070990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene mutation patterns of Chinese acute myeloid leukemia patients by targeted next-generation sequencing and bioinformatic analysis.
    Han X; Li W; He N; Feng P; Pang Y; Ji C; Ma D
    Clin Chim Acta; 2018 Apr; 479():25-37. PubMed ID: 29309772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of Residual Disease in Acute Myeloid Leukemia.
    Vedula RS; Lindsley RC
    Curr Hematol Malig Rep; 2017 Dec; 12(6):574-581. PubMed ID: 29064024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring.
    Luthra R; Patel KP; Reddy NG; Haghshenas V; Routbort MJ; Harmon MA; Barkoh BA; Kanagal-Shamanna R; Ravandi F; Cortes JE; Kantarjian HM; Medeiros LJ; Singh RR
    Haematologica; 2014 Mar; 99(3):465-73. PubMed ID: 24142997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular landscape and targeted therapy of acute myeloid leukemia.
    Gu R; Yang X; Wei H
    Biomark Res; 2018; 6():32. PubMed ID: 30455953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational spectrum of acute myeloid leukemia patients with double
    Su L; Tan Y; Lin H; Liu X; Yu L; Yang Y; Liu S; Bai O; Yang Y; Jin F; Sun J; Liu C; Liu Q; Gao S; Li W
    Oncotarget; 2018 May; 9(38):24970-24979. PubMed ID: 29861846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/
    Bill M; Mrózek K; Kohlschmidt J; Eisfeld AK; Walker CJ; Nicolet D; Papaioannou D; Blachly JS; Orwick S; Carroll AJ; Kolitz JE; Powell BL; Stone RM; de la Chapelle A; Byrd JC; Bloomfield CD
    Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26340-26346. PubMed ID: 33020282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencing.
    Mack EKM; Marquardt A; Langer D; Ross P; Ultsch A; Kiehl MG; Mack HID; Haferlach T; Neubauer A; Brendel C
    Haematologica; 2019 Feb; 104(2):277-287. PubMed ID: 30190345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications.
    Marando L; Huntly BJP
    Curr Oncol Rep; 2020 Jun; 22(6):61. PubMed ID: 32476069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of next-generation sequencing in diagnosis and monitoring of acute myeloid leukemia and myelodysplastic syndromes.
    Duncavage EJ; Tandon B
    Int J Lab Hematol; 2015 May; 37 Suppl 1():115-21. PubMed ID: 25976969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequencing-Based Measurable Residual Disease Testing in Acute Myeloid Leukemia.
    Yoest JM; Shirai CL; Duncavage EJ
    Front Cell Dev Biol; 2020; 8():249. PubMed ID: 32457898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemia.
    Lamba JK; Cao X; Raimondi SC; Rafiee R; Downing JR; Shi L; Gruber T; Ribeiro RC; Rubnitz JE; Pounds SB
    Oncotarget; 2018 Jul; 9(54):30473. PubMed ID: 30101002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.